Astrocytoma: A hormone-sensitive tumor? - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue International Journal of Molecular Sciences Année : 2020

Astrocytoma: A hormone-sensitive tumor?

Résumé

Astrocytomas and, in particular, their most severe form, glioblastoma, are the most aggressive primary brain tumors and those with the poorest vital prognosis. Standard treatment only slightly improves patient survival. Therefore, new therapies are needed. Very few risk factors have been clearly identified but many epidemiological studies have reported a higher incidence in men than women with a sex ratio of 1:4. Based on these observations, it has been proposed that the neurosteroids and especially the estrogens found in higher concentrations in women's brains could, in part, explain this difference. Estrogens can bind to nuclear or membrane receptors and potentially stimulate many different interconnected signaling pathways. The study of these receptors is even more complex since many isoforms are produced from each estrogen receptor encoding gene through alternative promoter usage or splicing, with each of them potentially having a specific role in the cell. The purpose of this review is to discuss recent data supporting the involvement of steroids during gliomagenesis and to focus on the potential neuroprotective role as well as the mechanisms of action of estrogens in gliomas.

Domaines

Cancer
Fichier principal
Vignette du fichier
Hirtz revue 2020.pdf (1.75 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03045654 , version 1 (08-12-2020)

Identifiants

Citer

Alex Hirtz, Fabien Rech, Hélène Dubois-Pot-Schneider, Hélène Dumond. Astrocytoma: A hormone-sensitive tumor?. International Journal of Molecular Sciences, 2020, 21 (23), pp.9114. ⟨10.3390/ijms21239114⟩. ⟨hal-03045654⟩
83 Consultations
67 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More